Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06409130
Status:
RECRUITING
Last Update Posted:
2024-07-05
First Post:
2024-05-07
Brief Title:
Effects of NNC0194-0499 Cagrilintide and Semaglutide Alone or in Combinations on Liver Damage and Alcohol Use in People With Alcohol-related Liver Disease
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-05-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-18
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09-06
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-07
First Submit QC Date:
May 7 2024
Study First Post Date:
2024-05-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-10
Last Update Post Date:
2024-07-05
Last Update Post Date Type:
ACTUAL